Related Experiment Video
Updated: Jun 21, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety
1Vascular and Endovascular Surgery Fellow, Arizona Heart Institute, 2632 North 20th Street, Phoenix, Arizona, 85006, USA. alex_kulik@yahoo.com
Insights
Statins significantly improve outcomes for patients undergoing coronary artery bypass graft (CABG) surgery, reducing mortality and complications. These cholesterol-lowering drugs are safe and beneficial both before and after CABG surgery.
Area of Science:
- Cardiology
- Pharmacology
- Surgical Outcomes
Background:
- Statins are proven to reduce cardiovascular events in native coronary artery disease.
- Statin use is underutilized in patients undergoing coronary artery bypass graft (CABG) surgery.
- Concerns exist regarding the perioperative safety of statins in CABG patients.
Purpose of the Study:
- To systematically review the safety and efficacy of statin therapy in patients undergoing coronary surgical revascularization.
- Evaluate the impact of statins administered before and after CABG surgery.
Main Methods:
- Systematic review of articles from the Medline database.
- Literature search conducted from 1987 to January 2009.
Main Results:
- Preoperative statins reduce perioperative mortality, stroke, and atrial fibrillation after CABG.
- Statins decrease the systemic inflammatory response to cardiopulmonary bypass.
- Postoperative statins inhibit graft disease and atherosclerosis progression, reducing cardiovascular events and improving mortality.
- Adverse effects of perioperative statins are rare.
Conclusions:
- Statins demonstrably improve outcomes for CABG patients, with benefits outweighing risks.
- Statin therapy should be initiated before CABG surgery in most patients.
- Optimal postoperative statin regimens require further investigation.
Background:
In patients with native coronary artery disease, strong evidence supports the use of statins to reduce the risk of recurrent cardiovascular events and improve survival. However, for patients undergoing coronary artery bypass graft surgery (CABG), statins appear to be underutilized, and concerns have been raised regarding their perioperative safety.
Objective:
The goal of this systematic review is to evaluate the safety and efficacy of statin therapy before and after coronary surgical revascularization.
Methods:
A systematic review was performed to retrieve relevant articles from the Medline database published between 1987 and January 2009.
Results:
Administered before CABG, statins have been demonstrated to reduce perioperative mortality, stroke and atrial fibrillation. Preoperative statin therapy also reduces the systemic inflammatory response associated with cardiopulmonary bypass. Following CABG, statins inhibit saphenous vein graft disease and the progression of atherosclerosis in native coronary arteries. In addition, postoperative statins reduce the recurrence of cardiovascular events and improve all-cause mortality. High-intensity lipid reduction to achieve low-density lipoprotein levels to 70 mg/dl may benefit post-CABG patients, but this has yet to be evaluated prospectively. Adverse effects related to perioperative statin therapy seem to be extremely rare, and little data are available to support the practice of withholding statin therapy before or after surgery.
Conclusion:
Numerous studies have demonstrated that statins improve the outcomes of patients undergoing CABG. The benefits seem to outweigh the risks associated with their use, both in the preoperative and postoperative period. In the absence of contraindications, essentially all CABG patients are candidates for life-long statin therapy that ideally should be started before surgery. The optimal postoperative statin regimen remains unknown and should be the subject of future study.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care